CONFIDENTIAL AMENDMENT NUMBER ONE to the COLLABORATION AGREEMENTCollaboration Agreement • June 1st, 2017 • Mersana Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJune 1st, 2017 Company IndustryThis AMENDMENT NUMBER ONE (this “Amendment”), dated February 21, 2013, amends the COLLABORATION AGREEMENT (the “Agreement”) is made as of July 25, 2012 (the “Effective Date”), by and between ADIMAB, LLC, a Delaware limited liability company having an address at 7 Lucent Drive, Lebanon, NH 03766 (“Adimab”) and MERSANA THERAPEUTICS, INC., a Delaware corporation having an address at 840 Memorial Drive, Cambridge, MA 02139 (“Mersana”).
CONFIDENTIAL AMENDMENT NUMBER ONE to the COLLABORATION AGREEMENTCollaboration Agreement • March 17th, 2017 • Mersana Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 17th, 2017 Company IndustryThis AMENDMENT NUMBER ONE (this “Amendment”), dated February 21, 2013, amends the COLLABORATION AGREEMENT (the “Agreement”) is made as of July 25, 2012 (the “Effective Date”), by and between ADIMAB, LLC, a Delaware limited liability company having an address at 7 Lucent Drive, Lebanon, NH 03766 (“Adimab”) and MERSANA THERAPEUTICS, INC., a Delaware corporation having an address at 840 Memorial Drive, Cambridge, MA 02139 (“Mersana”).